|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 110, Issue 7 861-870, Copyright © 1997 by Company of Biologists
JOURNAL ARTICLES |
D Greiling and RA Clark
Department of Dermatology, School of Medicine, SUNY at Stony Brook, New York 11794-8165, USA.
After injury, the wound space is filled with a fibrin/fibronectin clot containing growth factors released by platelets and monocytes. In response to these factors, fibroblasts migrate into the fibrin clot and contribute to the formation of granulation tissue. The functional mechanisms allowing fibroblasts to leave the collagenous matrix of normal connective tissue and invade the provisional matrix of the fibrin clot have not been fully defined. To investigate these mechanisms we established a new in vitro model which simulates specific aspects of early wound healing, that is, the migration of fibroblasts from a three-dimensional collagen matrix into a fibrin clot. This transmigration could be induced by physiological concentrations of platelet releasate or platelet-derived growth factor BB (PDGF-BB) in a concentration-dependent manner. At 24 hours irradiated fibroblasts invaded the fibrin gel almost as well as non-irradiated cells, indicating that transmigration was independent of proliferation. Plasminogen and its activators appear to be necessary for invasion of the fibrin clot since protease inhibitors decreased the amount of migration. These serine proteases, however, were not necessary for exit from the collagen gel as fibroblasts migrated out of the collagen gel onto a surface coated with fibrin fibrils even in the presence of inhibitors. Removal of fibronectin (FN) from either the collagen gel or the fibrin gel markedly decreased the number of migrating cells, suggesting that FN provides a conduit for transmigration. Cell movement in the in vitro model was inhibited by RGD peptide, and by monoclonal antibodies against the subunits of the alpha5 beta1 and alpha v beta3 integrin receptor. Thus, the functional requirements for fibroblast transmigration from collagen-rich to fibrin-rich matrices, such as occurs in early wound healing, have been partially defined using an in vitro paradigm of this important biologic process.
This article has been cited by other articles:
|
|
 |
|
  M. S. Agren and M. Werthen The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds International Journal of Lower Extremity Wounds, June 1, 2007; 6(2): 82 - 97. [Abstract] [PDF]
|
|
|
|
 |
|
 T. A. Dugan, V. W.-C. Yang, D. J. McQuillan, and M. Hook Decorin Modulates Fibrin Assembly and Structure J. Biol. Chem., December 15, 2006; 281(50): 38208 - 38216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, C.-H. Heldin, and P. Heldin Inhibition of Platelet-derived Growth Factor-BB-induced Receptor Activation and Fibroblast Migration by Hyaluronan Activation of CD44 J. Biol. Chem., September 8, 2006; 281(36): 26512 - 26519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. de Giorgio-Miller, S. Bottoms, G. Laurent, P. Carmeliet, and S. Herrick Fibrin-Induced Skin Fibrosis in Mice Deficient in Tissue Plasminogen Activator Am. J. Pathol., September 1, 2005; 167(3): 721 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jia, Z.-Z. Zeng, S. M. Markwart, K. F. Rockwood, K. M. W. Ignatoski, S. P. Ethier, and D. L. Livant Integrin Fibronectin Receptors in Matrix Metalloproteinase-1-Dependent Invasion by Breast Cancer and Mammary Epithelial Cells Cancer Res., December 1, 2004; 64(23): 8674 - 8681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fontaine, Z. Touat, E. M. Mtairag, R. Vranckx, L. Louedec, X. Houard, B. Andreassian, U. Sebbag, T. Palombi, M.-P. Jacob, et al. Role of Leukocyte Elastase in Preventing Cellular Re-Colonization of the Mural Thrombus Am. J. Pathol., June 1, 2004; 164(6): 2077 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zoppi, R. Gardella, A. De Paepe, S. Barlati, and M. Colombi Human Fibroblasts with Mutations in COL5A1 and COL3A1 Genes Do Not Organize Collagens and Fibronectin in the Extracellular Matrix, Down-regulate {alpha}2{beta}1 Integrin, and Recruit {alpha}v{beta}3 Instead of {alpha}5{beta}1 Integrin J. Biol. Chem., April 30, 2004; 279(18): 18157 - 18168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Li, S. D. Redick, H. P. Erickson, and V. T. Moy Force Measurements of the {alpha}5{beta}1 Integrin-Fibronectin Interaction Biophys. J., February 1, 2003; 84(2): 1252 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Cai, S. Koltai, E. Kocsis, D. Scholz, S. Kostin, X. Luo, W. Schaper, and J. Schaper Remodeling of the adventitia during coronary arteriogenesis Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H31 - H40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Majors, S. Sengupta, B. Willard, M. T. Kinter, R. E. Pyeritz, and D. W. Jacobsen Homocysteine Binds to Human Plasma Fibronectin and Inhibits Its Interaction With Fibrin Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1354 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Hotary, I. Yana, F. Sabeh, X.-Y. Li, K. Holmbeck, H. Birkedal-Hansen, E. D. Allen, N. Hiraoka, and S. J. Weiss Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP-dependent and -independent Processes J. Exp. Med., January 28, 2002; 195(3): 295 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Haugh, F. Codazzi, M. Teruel, and T. Meyer Spatial Sensing in Fibroblasts Mediated by 3' Phosphoinositides J. Cell Biol., December 11, 2000; 151(6): 1269 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cooke, T Sakai, and D. Mosher Contraction of collagen matrices mediated by alpha2beta1A and alpha(v)beta3 integrins J. Cell Sci., January 7, 2000; 113(13): 2375 - 2383. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Olman, J. S. Hagood, W. L. Simmons, G. M. Fuller, C. Vinson, and K. E. White Fibrin Fragment Induction of Plasminogen Activator Inhibitor Transcription Is Mediated by Activator Protein-1 Through a Highly Conserved Element Blood, September 15, 1999; 94(6): 2029 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Singer and R. A.F. Clark Cutaneous Wound Healing N. Engl. J. Med., September 2, 1999; 341(10): 738 - 746. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Corbett and J. E. Schwarzbauer Requirements for alpha 5beta 1 Integrin-mediated Retraction of Fibronectin-Fibrin Matrices J. Biol. Chem., July 23, 1999; 274(30): 20943 - 20948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Phillips New Skin for Old: Developments in Biological Skin Substitutes Arch Dermatol, March 1, 1998; 134(3): 344 - 349. [Full Text] [PDF]
|
|
|
|
|
|
H Stanton, J Gavrilovic, S. Atkinson, M. d'Ortho, K. Yamada, L Zardi, and G Murphy The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form J. Cell Sci., January 9, 1998; 111(18): 2789 - 2798. [Abstract] [PDF]
|
|
